Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.

@article{Dostl2013PregnancyOF,
  title={Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.},
  author={Michal Dost{\'a}l and Corinna Weber-Schoendorfer and Jan Sobesky and Christof Schaefer},
  journal={European journal of neurology},
  year={2013},
  volume={20 9},
  pages={1241-6}
}
BACKGROUND Restless legs syndrome (RLS) is related to parity, and its symptoms may worsen during pregnancy. Treatment with levodopa or dopamine agonists is the first-line therapy for RLS; however, there are limited data on treatment in pregnancy. We therefore assessed the safety of levodopa, pramipexole, rotigotine, and ropinirole in pregnancy. METHODS Prospective documentation of pregnancies exposed to levodopa, pramipexole, rotigotine, and ropinirole between 1998 and 2011 was evaluated as… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Pharmacological treatment of sleep disorders and its relationship with neuroplasticity.

Current topics in behavioral neurosciences • 2015
View 8 Excerpts
Highly Influenced

Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders

Journal of Inherited Metabolic Disease • 2018
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Prolactinomas and pregnancy.

Clinical endocrinology • 2010

Similar Papers

Loading similar papers…